Invitae
NVTA
$0.01950
Share price
0.00%
Change (1 day)
-98.19%
Change (1 year)
Earnings for Invitae (NVTA)
Earnings in 2023 (TTM): -$1.46 B
According to Invitae 's latest financial reports the company's current earnings (TTM) are -$1.46 B. In 2022 the company made an earning of -$3.16 B a decrease over its 2021 earnings that were of -$0.42 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Invitae from 2014 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$1.46 B | -53.86% |
| 2022 | -$3.16 B | 657.75% |
| 2021 | -$0.42 B | -41.78% |
| 2020 | -$0.72 B | 174.28% |
| 2019 | -$0.27 B | 97.05% |
| 2018 | -$0.14 B | 5.52% |
| 2017 | -$0.13 B | 24.92% |
| 2016 | -$0.11 B | 11.67% |
| 2015 | -$89.79 M | 89.05% |
| 2014 | -$47.5 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Celldex Therapeutics CLDX | -$0.15 B | -90.23% | 🇺🇸 USA |
 HTG Molecular Diagnostics
HTGM | -$19.53 M | -98.66% | 🇺🇸 USA |
 CareDx CDNA | -$0.11 B | -92.80% | 🇺🇸 USA |